Facebook Twitter LinkedIn Google Plus RSS

Cyclacel announces sale of four patents to Celgene, dismissal of litigation

By ,

Cyclacel Pharmaceuticals Inc., in Berkeley Heights, announced today it will sell Celgene Corp., in Summit, four Cyclacel-owned patents in a $5.5 million deal.

According to an announcement, as a result of the agreement, Cyclacel and Celgene have filed a joint stipulation and order for dismissal requesting the court enter an order dismissing a patent litigation dispute between the companies.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy